These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 17221856

  • 1. Esophageal Crohn's disease treated successfully with adalimumab.
    Kwan LY, Conklin JL, Papadakis KA.
    Inflamm Bowel Dis; 2007 May; 13(5):639-40. PubMed ID: 17221856
    [No Abstract] [Full Text] [Related]

  • 2. Distal esophageal involvement in Crohn disease: short treatment with adalimumab.
    Musto D, Martorelli L, Cirillo A, Selvaggi F, Esposito P, Russo MI, Riegler G.
    Endoscopy; 2010 May; 42 Suppl 2():E299. PubMed ID: 21113880
    [No Abstract] [Full Text] [Related]

  • 3. Closure of perianal fistula using adalimumab in a Crohn's disease patient naive to antitumor necrosis factor alpha antibodies.
    Malesci A, Angelucci E, Bonifacio C, Sociale O, Omodei P, Repici A, Balzarini L, Danese S.
    Inflamm Bowel Dis; 2009 Jun; 15(6):814-5. PubMed ID: 18831523
    [No Abstract] [Full Text] [Related]

  • 4. Adalimumab for cutaneous metastatic Crohn's disease.
    Cury DB, Moss AC, Elias G, Nakao A.
    Inflamm Bowel Dis; 2010 May; 16(5):723-4. PubMed ID: 19728388
    [No Abstract] [Full Text] [Related]

  • 5. Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature.
    Jürgens M, Brand S, Filik L, Hübener C, Hasbargen U, Beigel F, Tillack C, Göke B, Ochsenkühn T, Seiderer J.
    Inflamm Bowel Dis; 2010 Oct; 16(10):1634-6. PubMed ID: 20027647
    [No Abstract] [Full Text] [Related]

  • 6. Successful treatment of refractory esophageal Crohn's disease with infliximab.
    Fefferman DS, Shah SA, Alsahlil M, Gelrud A, Falchulk KR, Farrell RJ.
    Dig Dis Sci; 2001 Aug; 46(8):1733-5. PubMed ID: 11508675
    [No Abstract] [Full Text] [Related]

  • 7. Commentary: infliximab or adalimumab in Crohn's disease?
    Sprakes MB, Hamlin PJ.
    Aliment Pharmacol Ther; 2012 Aug; 36(4):398. PubMed ID: 22803644
    [No Abstract] [Full Text] [Related]

  • 8. Letter: infliximab and adalimumab in the management of Crohn's disease--are they really comparable?
    Lopez-Sanroman A, Gisbert JP.
    Aliment Pharmacol Ther; 2012 Sep; 36(5):498-9. PubMed ID: 22860615
    [No Abstract] [Full Text] [Related]

  • 9. [Adalimumab in Crohn's disease - data from real life].
    López San Román A, Van Domselaar M, Garrido E.
    Rev Esp Enferm Dig; 2008 Nov; 100(11):671-5. PubMed ID: 19159169
    [No Abstract] [Full Text] [Related]

  • 10. Letter: are infliximab and adalimumab similar for Crohn's disease in clinical practice?
    Tursi A, Elisei W, Picchio M, Penna A.
    Aliment Pharmacol Ther; 2013 Apr; 37(7):763-4. PubMed ID: 23458543
    [No Abstract] [Full Text] [Related]

  • 11. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.
    Haennig A, Bonnet D, Thebault S, Alric L.
    Gastroenterol Clin Biol; 2010 Sep; 34(8-9):e7-8. PubMed ID: 20189334
    [No Abstract] [Full Text] [Related]

  • 12. Fulminant Crohn's colitis: when only an antibody will do.
    Ng SC, Kamm MA.
    Inflamm Bowel Dis; 2007 Aug; 13(8):971-4. PubMed ID: 17427240
    [Abstract] [Full Text] [Related]

  • 13. Crohn's disease: Adalimumab improves quality of life.
    Papadakis KA.
    Nat Rev Gastroenterol Hepatol; 2009 Apr; 6(4):200-1. PubMed ID: 19347008
    [No Abstract] [Full Text] [Related]

  • 14. First case report of adalimumab-induced psoriasis in Crohn's disease.
    Harris MD, Richards R.
    Am J Gastroenterol; 2009 Mar; 104(3):792-3. PubMed ID: 19262532
    [No Abstract] [Full Text] [Related]

  • 15. Duodenal Crohn's disease successfully treated with adalimumab.
    Tursi A.
    Endoscopy; 2011 Mar; 43 Suppl 2 UCTN():E22. PubMed ID: 21271523
    [No Abstract] [Full Text] [Related]

  • 16. Esophageal ulcer of Crohn's disease: disappearance in 1 week with infliximab.
    Chiba M, Sugawara T, Tsuda H, Abe T, Tokairin T, Kashima Y.
    Inflamm Bowel Dis; 2009 Aug; 15(8):1121-2. PubMed ID: 18942761
    [No Abstract] [Full Text] [Related]

  • 17. [Oligosymptomatic alimentary tract perforation in course of Crohn's disease in patient treated with anti-TNF alfa antibodies].
    Jałocha Ł, Wojtuń S, Wojtkowiak M, Błaszak A, Dyrla P, Gil J.
    Pol Merkur Lekarski; 2009 May; 26(155):491-2. PubMed ID: 19606707
    [Abstract] [Full Text] [Related]

  • 18. Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study.
    Condino G, Calabrese E, Zorzi F, Onali S, Lolli E, De Biasio F, Ascolani M, Pallone F, Biancone L.
    Dig Liver Dis; 2013 Mar; 45(3):258-62. PubMed ID: 23195667
    [Abstract] [Full Text] [Related]

  • 19. Cutaneous Crohn's disease presenting as genital warts: successful treatment with adalimumab.
    Lestre S, Ramos J, João A, Serrão V.
    Eur J Dermatol; 2010 Mar; 20(4):504-5. PubMed ID: 20507839
    [No Abstract] [Full Text] [Related]

  • 20. Oropharyngeal and proximal esophageal involvement during adalimumab treatment of Crohn disease.
    Nguyen KD, Alexis R, Schwarz SM.
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):225-6. PubMed ID: 19841594
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.